Latest News and Press Releases

TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients,...

TORONTO, May 12, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. is pleased to announce the selection of PSI CRO to manage its phase 3 clinical study of PNT2002, a 177Lu-PSMA radiotherapeutic for the...

TORONTO, April 07, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. is pleased to announce the formation of its global prostate oncology therapeutic advisory board.  The Board, comprised of leading...

TORONTO, March 24, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. today announced the appointment of Todd Hockemeyer as Executive Vice President of US Manufacturing Operations. An industrial...

TORONTO and MUNICH, Germany, March 10, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma Inc. today announced that it has entered into an agreement with SCINTOMICS GmbH for the exclusive use and development...

-APPOINTS LEADERSHIP - TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- POINT Biopharma, a newly formed pharmaceutical company, is combining a seasoned management team with strategic partnerships in...